Favism and glucose-6-phosphate dehydrogenase deficiency

New England Journal of Medicine

Volumn 378, Issue 1, 2018, Pages 60-71

  Luzzatto, Lucio ^a   Arese, Paolo ^b  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; DIVICINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; PRIMAQUINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TAFENOQUINE; FREE RADICAL; GLUCOSIDE; PYRIMIDINONE DERIVATIVE; VICINE;

DRUG WITHDRAWAL; FAVISM; GENETIC HETEROGENEITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH EDUCATION; HEMOGLOBINURIA; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; MALARIA FALCIPARUM; NEWBORN JAUNDICE; NEWBORN SCREENING; NONHUMAN; PLASMODIUM VIVAX MALARIA; PREVALENCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SCREENING TEST; SINGLE DRUG DOSE; VICIA FABA; X CHROMOSOME INACTIVATION; CHEMISTRY; COMPLICATION; ERYTHROCYTE; GENETICS; METABOLISM; PATHOLOGY;

ERYTHROCYTES; FAVISM; FREE RADICALS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; GLUCOSIDES; HUMANS; PYRIMIDINONES; VICIA FABA;

EID: 85040351018     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1708111     Document Type: Review

References (102)

1. Meletis J, Konstantopoulos L. Favism - from the "avoid fava beans" of Pythagoras to the present. Haema 2004;7:17-21.
2. Simoons FJ. Plants of life plants of death. Madison: University of Wisconsin Press, 1998.
3. Alving AS, Carson PE, Flanagan CL, Ickes CE. Enzymatic deficiency in primaquinesensitive erythrocytes. Science 1956;124:484-5.
4. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1991;324:169-74.
5. Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev 2007;21:267-83.
6. Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am 2016;30:373-93.
7. Fermi C, Martinetti P. Studio sul favismo. Ann Ig Sper 1905;15:76-112.
8. Luisada A. A singular disease affecting chiefly red blood cells. Medicine (Baltimore) 1941;20:229-50.
9. Belsey MA. The epidemiology of favism. Bull World Health Organ 1973;48:1-13.
10. Zohary D, Hopf M. Domestication of pulses in the Old World: legumes were companions of wheat and barley when agriculture began in the Near East. Science 1973;182:887-94.
11. Kislev ME, Bar-Yosef O. The legumes: the earliest domesticated plants in the Near East? Curr Anthropol 1988;29:175-9.
12. Multari S, Stewart D, Russell WR. Potential of fava bean as a future protein supply to partially replace meat intake in the human diet. Comp Rev Food Sci Food Saf 2015;14:511-22.
13. Chevion M, Navok T, Glaser G, Mager J. The chemistry of favism-inducing compounds: the properties of isouramil and divicine and their reaction with glutathione. Eur J Biochem 1982;127:405-9.
14. Arese P, De Flora A. Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency. Semin Hematol 1990;27:1-40.
15. Pavlik M, Vanova M, Laudova V, Harmatha J. Fungitoxicity of natural heterocycle glucoside vicine obtained from Vicia faba L. against selected filamentous fungi. Rostlinna Vyroba 2002;48:543-7.
16. Desroches P, El Shazly E, Mandon N, Duc G, Huignard J. Development of Callosobrucus chinensis (L.) and C. maculatus (F.) (Coleoptera: bruchidae) in seeds of Vicia faba L. differing in their tannin, vicine and convicine contents. J Stored Prod Res 1995;31:83-9.
17. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989;67:601-11.
18. Meloni T, Forteleoni G, Dore A, Cutillo S. Favism and hemolytic anemia in glucose-6-phosphate dehydrogenase-deficient subjects in North Sardinia. Acta Haematol 1983;70:83-90.
19. Reading NS, Sirdah MM, Shubair ME, et al. Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community. Blood Cells Mol Dis 2016;60:58-64.
20. Pamba A, Richardson ND, Carter N, et al. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood 2012;120:4123-33.
21. Kalfa TA. Warm antibody autoimmune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2016. 2016(1):690-7.
22. Luzzatto L, Poggi VE. Glucose-6-phosphate dehydrogenase deficiency. In: Orkin SH, Fisher DE, Ginsburg D, Look AT, Lux SE, Nathan DG, eds. Nathan and Oski's hematology and oncology of infancy and childhood. Philadelphia: Elsevier-Saunders, 2015:609-29.
23. Chan TK, Chan WC, Weed RI. Erythrocyte hemighosts: a hallmark of severe oxidative injury in vivo. Br J Haematol 1982;50:575-82.
24. Fischer TM, Meloni T, Pescarmona GP, Arese P. Membrane cross bonding in red cells in favic crisis: a missing link in the mechanism of extravascular haemolysis. Br J Haematol 1985;59:159-69.
25. Iolascon A, Faienza MF, Giordani L, et al. Bilirubin levels in the acute hemolytic crisis of G6PD deficiency are related to Gilbert's syndrome. Eur J Haematol 1999;62:307-10.
26. Odièvre MH, Danékova N, Mesples B, et al. Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy. Int J Hematol 2011;93:664-6.
27. Albano E, Tomasi A, Mannuzzu L, Arese P. Detection of a free radical intermediate from divicine of Vicia faba. Biochem Pharmacol 1984;33:1701-4.
28. Winterbourn CC, Benatti U, De Flora A. Contributions of superoxide, hydrogen peroxide, and transition metal ions to auto-oxidation of the favism-inducing pyrimidine aglycone, divicine, and its reactions with haemoglobin. Biochem Pharmacol 1986;35:2009-15.
29. Gaetani GF, Galiano S, Canepa L, Ferraris A-M, Kirkman HN. Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood 1989;73:334-9.
30. McMillan DC, Bolchoz LJ, Jollow DJ. Favism: effect of divicine on rat erythrocyte sulfhydryl status, hexose monophosphate shunt activity, morphology, and membrane skeletal proteins. Toxicol Sci 2001;62:353-9.
31. Kamerbeek NM, van Zwieten R, de Boer M, et al. Molecular basis of glutathione reductase deficiency in human blood cells. Blood 2007;109:3560-6.
32. Gaetani GF, Mareni C, Salvidio E, Galiano S, Meloni T, Arese P. Favism: erythrocyte metabolism during haemolysis and reticulocytosis. Br J Haematol 1979;43:39-48.
33. Skorokhod A, Schwarzer E, Gremo G, Arese P. HNE produced by the malaria parasite Plasmodium falciparum generates HNE-protein adducts and decreases erythrocyte deformability. Redox Rep 2007;12:73-5.
34. Ferrali M, Signorini C, Ciccoli L, Comporti M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem J 1992;285:295-301.
35. Lachmann PJ, Hughes-Jones NC. Initiation of complement activation. Springer Semin Immunopathol 1984;7(2. 3):143-62.
36. Turrini F, Naitana A, Mannuzzu L, Pescarmona G, Arese P. Increased red cell calcium, decreased calcium adenosine triphosphatase, and altered membrane proteins during fava bean hemolysis in glucose-6-phosphate dehydrogenase-deficient (Mediterranean variant) individuals. Blood 1985;66:302-5.
37. Arese P, Turrini F, Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005;16:133-46.
38. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005;293:1653-62.
39. Tarlov AR, Brewer GJ, Carson PE, Alving AS. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. Arch Intern Med 1962;109:209-34.
40. Kaplan M, Hammerman C. Severe neonatal hyperbilirubinemia: a potential complication of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol 1998;25:575-590, viii.
41. Brodribb HS. Favism from pollen. BMJ 1966;2:642.
42. Pitz WJ, Sosulski FW, Hogge LR. Occurrence of vicine and convicine in seeds of some Vicia species and other pulses. Can Inst Food Sci Technol 1980;13:35-9.
43. Griffiths DW, Ramsay G. The distribution of vicine and convicine in Vicia faba and some related species and their distribution within mature seeds. J Sci Food Agric 1992;59:463-9.
44. Bicakci Z. A hemolysis trigger in glucose-6-phosphate dehydrogenase enzyme deficiency: Vicia sativa (Vetch). Saudi Med J 2009;30:292-4.
45. Farran MT, Darwish AH, Uwayjan MG, Sleiman FT, Ashkarian VM. Vicine and convicine in common vetch (Vicia sativa) seeds enhance beta-cyanoalanine toxicity in male broiler chicks. Int J Toxicol 2002;21:201-9.
46. Zuccotti GV, Redaelli F, Gualdi V, et al. Hemolytic crisis in a G6PD-deficient infant after ingestion of pumpkin. Ital J Pediatr 2014;40:71.
47. Cardador-Martinez A, Maya-Ocana K, Ortiz-Moreno A. Effect of roasting and boiling on the content of vicine, convicine and L-3, 4-dihydroxyphenylalanine in Vicia faba L. J Food Qual 2012;35:419-28.
48. Pulkkinen M, Zhou X, Lampi AM, Piironen V. Determination and stability of divicine and isouramil produced by enzymatic hydrolysis of vicine and convicine of faba bean. Food Chem 2016;212:10-9.
49. Griffiths DW, Ramsay G. The distribution of pyrimidinone glucosides in developing seedlings of Vicia faba and Vicia narbonensis. J Sci Food Agric 1996;72:469-75.
50. Khamassi K, Jeddi FB, Hobbs D, et al. A baseline study of vicine-convicine levels in faba bean (Vicia faba L) germplasm. Plant Genet Resour 2013;11:250-7.
51. Beutler E, Yeh M, Fairbanks VF. The normal human female as a mosaic of Xchromosome activity: studies using the gene for C-6-PD-deficiency as a marker. Proc Natl Acad Sci U S A 1962;48:9-16.
52. Rinaldi A, Filippi G, Siniscalco M. Variability of red cell phenotypes between and within individuals in an unbiased sample of 77 heterozygotes for G6PD deficiency in Sardinia. Am J Hum Genet 1976;28:496-505.
53. Gall JC, Brewer GJ, Dern RJ. Studies of glucose 6-phosphate dehydrogenase activity of individual erythrocytes: the methemoglobinelution test for the detection of females heterozygous for G6PD deficiency. Am J Hum Genet 1965;17:359-68.
54. Vogels IMC, Van Noorden CJF, Wolf BHM, et al. Cytochemical determination of heterozygous glucose-6-phosphate dehydrogenase deficiency in erythrocytes. Br J Haematol 1986;63:402-5.
55. Shah SS, Diakite SA, Traore K, et al. A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency. Sci Rep 2012;2:299.
56. Martini G, Toniolo D, Vulliamy T, et al. Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J 1986;5:1849-55.
57. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood Cells Mol Dis 2012;48:154-65.
58. Longo L, Vanegas OC, Patel M, et al. Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J 2002;21:4229-39.
59. Piomelli S, Corash LM, Davenport DD, Miraglia J, Amorosi EL. In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency. J Clin Invest 1968;47:940-8.
60. Morelli A, Benatti U, Gaetani GF, De Flora A. Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency. Proc Natl Acad Sci U S A 1978;75:1979-83.
61. Calabro V, Cascone A, Malaspina P, Battistuzzi G. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A (-) associated with favism. Haematologica 1989;74:71-3.
62. Nafa K, Reghis A, Osmani N, et al. G6PD Aures: a new mutation (48 Ile→Thr) causing mild G6PD deficiency is associated with favism. Hum Mol Genet 1993;2:81-2.
63. Galiano S, Gaetani GF, Barabino A, et al. Favism in the African type of glucose-6-phosphate dehydrogenase deficiency (A-). BMJ 1990;300:236.
64. Laosombat V, Sattayasevana B, Chotsampancharoen T, Wongchanchailert M. Glucose-6-phosphate dehydrogenase variants associated with favism in Thai children. Int J Hematol 2006;83:139-43.
65. Vulliamy TJ, D'Urso M, Battistuzzi G, et al. Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc Natl Acad Sci U S A 1988;85:5171-5.
66. Goncalves P, Ribeiro ML, Tamagnini G, Kaeda J, Youssof N, Vulliamy TJ. Favism: glucose 6 phosphate dehydrogenase deficiency, G6PD A-: a common occurrence among Portuguese children. Br J Haematol 1994;87:Suppl 1:146.
67. Benmansour I, Moradkhani K, Moumni I, et al. Two new class III G6PD variants [G6PD Tunis (c.920A>C: p. 307Gln>Pro) and G6PD Nefza (c.968T>C: p. 323 Leu>Pro)] and overview of the spectrum of mutations in Tunisia. Blood Cells Mol Dis 2013;50:110-4.
68. Calabro V, Mason PJ, Filosa S, et al. Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis. Am J Hum Genet 1993;52:527-36.
69. Rovira A, Vulliamy TJ, Pujades A, Luzzatto L, Corrons JL. The glucose-6-phosphate dehydrogenase (G6PD) deficient variant G6PD Union (454 Arg→ys) has a worldwide distribution possibly due to recurrent mutation. Hum Mol Genet 1994;3:833-5.
70. Laosombat V, Sattayasevana B, Janejindamai W, et al. Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in the south of Thailand and identification of a novel variant (G6PD Songklanagarind). Blood Cells Mol Dis 2005;34:191-6.
71. Noori-Daloii MR, Najafi L, Mohammad Ganji S, Hajebrahimi Z, Sanati MH. Molecular identification of mutations in G6PD gene in patients with favism in Iran. J Physiol Biochem 2004;60:273-7.
72. Yoshida A, Beutler E, Motulsky AG. Human glucose-6-phosphate dehydrogenase variants. Bull World Health Organ 1971;45:243-53.
73. Jablonska-Skwiecinska E, Lewandowska I, Plochocka D, et al. Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism. Hum Mutat 1999;14:477-84.
74. van Wijk R, Huizinga EG, Prins I, et al. Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis 2004;32:112-7.
75. Beutler E, Kuhl W, Vives-Corrons JL, Prchal JT. Molecular heterogeneity of glucose-6-phosphate dehydrogenase A-. Blood 1989;74:2550-5.
76. Maiga B, Dolo A, Campino S, et al. Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali. Malar J 2014;13:270.
77. Sirugo G. Reassessing an old claim: natural selection of hemizygotes and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Am J Hematol 2013;88:436.
78. Monteiro WM, Franca GP, Melo GC, et al. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes. Malar J 2014;13:70.
79. Rovira A, Vulliamy T, Pujades MA, Luzzatto L, Corrons JL. Molecular genetics of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain: identification of two new point mutations in the G6PD gene. Br J Haematol 1995;91:66-71.
80. Luzzatto L. Genetics of red cells and susceptibility to malaria. Blood 1979;54:961-76.
81. Bunn HF. The triumph of good over evil: protection by the sickle gene against malaria. Blood 2013;121:20-5.
82. Motulsky AG. Metabolic polymorphisms and the role of infectious diseases in human evolution. Hum Biol 1960;32:28-62.
83. Allison AC. Glucose-6-phosphate dehydrogenase deficiency in red blood cells of East Africans. Nature 1960;186:531-2.
84. Luzzatto L, Usanga FA, Reddy S. Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Science 1969;164:839-42.
85. Luzzatto L. G6PD deficiency and malaria selection. Heredity (Edinb) 2012;108:456.
86. Malaria Genomic Epidemiology Network. Reappraisal of known malaria resistance loci in a large multicenter study. Nat Genet 2014;46:1197-204.
87. Uyoga S, Carolyne M, Ndila CM, et al. Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children on the coast of Kenya: a case-control and a cohort study. Lancet Haematol 2015;2(10):e437-e444.
88. Luzzatto L. G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria. Lancet Haematol 2015;2(10):e400-e401.
89. Louicharoen C, Patin E, Paul R, et al. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science 2009;326:1546-9.
90. John GK, Douglas NM, von Seidlein L, et al. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J 2012;11:280.
91. White NJ, Qiao LG, Qi G, Luzzatto L. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J 2012;11:418.
92. Baird K. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria. Pathog Glob Health 2015;109:93-106.
93. von Fricken ME, Weppelmann TA, Eaton WT, et al. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Ouest and Sud-Est departments of Haiti. Acta Trop 2014;135:62-6.
94. Bhutani VK, Kaplan M, Glader B, Cotten M, Kleinert J, Pamula V. Point-of-care quantitative measure of glucose-6-phosphate dehydrogenase enzyme deficiency. Pediatrics 2015;136(5):e1268-e1275.
95. Motulsky AG, Campbell-Kraut JM. Population genetics of glucose 6-phosphate dehydrogenase deficiency of the red cell. In: Blumberg BS, ed. Proceedings of conference on genetic polymorphisms and geographic variations in disease. New York: Grune & Stratton, 1961:159-80.
96. Brewer GJ, Tarlov AR, Alving AS. The methemoglobin reduction test for primaquinetype sensitivity of erythrocytes: a simplified procedure for detecting a specific hypersusceptibility to drug hemolysis. JAMA 1962;180:386-8.
97. Rueangweerayut R, Bancone G, Harrell EJ, et al. Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers. Am J Trop Med Hyg 2017;97:702-11.
98. Chu CS, Bancone G, Moore KA, et al. Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens. PLoS Med 2017;14(2):e1002224.
99. Meloni T, Forteleoni G, Meloni GF. Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience. Acta Haematol 1992;87:29-31.
100. Darbandi B, Noghbaei M, Mehrabian F, Jafroodi M. Medical expenses of patients with favism admitted to 17th Shahrivar Hospital compared to G6PD enzyme screening cost, in north of Iran. Iran J Ped Hematol Oncol 2014;4:53-6.
101. Gutierrez N, Avila CM, Duc G, et al. CAPs markers to assist selection for low vicine and convicine contents in faba bean (Vicia faba L.). Theor Appl Genet 2006;114:59-66.
102. Hendawey MH, Younes AMA. Biochemical evaluation of some faba bean cultivars under rainfed conditions at El-Sheikh Zuwayid. Ann Agric Sci 2013;58:183-93.